Innovations in Predictive 3D Modeling of Live Human Cells, Vaccine Development, Gene Editing, and Targeted Protein Degradation Platforms

  • ID: 4580154
  • Report
  • Region: Global
  • 15 Pages
  • Frost & Sullivan
1 of 3

This edition of the Genetic Technology TOE depicts life sciences trends across predictive 3D modeling of live human cells, vaccine development, gene editing, and targeted protein degradation platforms. The corresponding clinical trials scenario is also covered.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 3

Recent Advances in Predictive 3D Modeling of Live Human Cells, Vaccine Development, Gene Editing, and Targeted Protein Degradation Platforms

  • Artificial Intelligence that Delivers Predictive 3D View Inside a Living Human Cell
  • A Potential Vaccine to Suppress Food Allergies
  • Precise Gene Editing with ARCUS
  • Exploiting Ubiquitin Proteosome Mechanism to Drug Undruggable Proteins

Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis of RNAi drugs for Hereditary Amyloidosis
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll